Araştırma Makalesi

Lung injury aggravated in Streptozotocin-induced diabetes: an experimental study

Cilt: 47 Sayı: 1 31 Mart 2022
Demet Bolat , Menekşe Ülger , Münevver Baran , Işıl Tuğçe Turan , Arzu Yay *
PDF İndir
EN TR

Lung injury aggravated in Streptozotocin-induced diabetes: an experimental study

Abstract

Purpose: The aim of the study explores the impact and potential mechanisms on the STZ (Streptozotocin)-induced diabetes model histopathologically and immunohistochemically on diabetic lung fibrosis. Materials and Methods: In this study, 14 adult female Wistar albino rats were divided into groups of seven random animals: the control and STZ induced diabetic groups. In the study, a blood glucose level above 200 mg/dl was accepted as diabetes. Nine days after the experiment, the rats were sacrificed under anesthesia and lung samples were taken from each. The histopathological appearance of the samples was evaluated and histopathologic damage score was performed. Apoptosis and inflammation in tissues were evaluated with caspase-3 and IL-1β immunohistochemically. Results: In the histopathological examination, the STZ group had a higher histopathologic damage score than the control group, and there were findings such as vascular congestion, thickened alveolar wall, and inflammatory cell infiltration. In the caspase-3 immunohistochemistry, staining of the lung tissues of the STZ group was higher than the control group. This difference was also significant in terms of IL-1β immunoreactivity intensity. Conclusion: This study determined that lung complications and damage due to diabetes-induced by STZ occurred.

Keywords

Diabetes mellitus , lung , streptozotocin , apoptosis

Kaynakça

  1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843..
  2. Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2017;3:3-10.
  3. Fontaine-Delaruelle C, Viart-Ferber C, Luyton C, Couraud S. Lung function in patients with diabetes mellitus. Rev Pneumol Clin. 2016;72:10-6.
  4. Zou XZ, Gong ZC, Liu T, He F, Zhu TT, Li Dai et al. Involvement of epithelial mesenchymal transition afforded by activation of LOX1/TGF-beta1/KLF6 signaling pathway in diabetic pulmonary fibrosis. Pulm Pharmacol Ther. 2017;44:70-77.
  5. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656-65.
  6. Wang LM, Zhong NZ, Liu SJ, Zhu XY, Liu YJ. Hypoxia-induced acute lung injury is aggravated in Streptozotocin diabetic mice. Exp Lung Res. 2015; 41:146-54.
  7. Johnson DR, O’Connor JC, Hartman ME, Tapping RI, Freund GG. Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. J Neurosci. 2007;27:1161–66.
  8. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J. 2016;24:547-53.
  9. Sala E, Vived C, Luna J et al. CDK11 promotes cytokine-induced apoptosis in pancreatic beta cells independently of glucose concentration and is regulated by inflammation in the NOD mouse model. Front Immunol. 2021;12:634797.
  10. Yilmaz BO, Yildizbayrak N, Aydin Y, Erkan M. Evidence of acrylamide- and glycidamide-induced oxidative stress and apoptosis in Leydig and Sertoli cells. Hum Exp Toxicol. 2017;36:1225-35.

Kaynak Göster

MLA
Bolat, Demet, vd. “Lung injury aggravated in Streptozotocin-induced diabetes: an experimental study”. Cukurova Medical Journal, c. 47, sy 1, Mart 2022, ss. 175-82, doi:10.17826/cumj.1020617.